SAN DIEGO, March 25, 2025 — Sugar coatings aren’t only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts’ immune system. Now, researchers have developed a ...

VBI Vaccines Inc. said Wednesday the first clinical data from a Phase I trial of a pan-coronavirus vaccine candidate produced broad and durable protection against COVID-19 variants of concern. Ciara ...

DURHAM, N.C. (WTVD) -- A team of scientists with the Duke Human Vaccine Institute have created a vaccine which showed promising results in animals against the original COVID-19 strain and other ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today ...

Preclinical studies using a “future-proof” vaccine technology developed by researchers at the University of Cambridge have shown that just one antigen can be modified to provide a broadly protective ...

WASHINGTON -- At the dawn of the COVID-19 pandemic, vaccine makers raced to design a shot that perfectly matched the new virus's genetic code. Their efforts were successful, resulting in highly ...

Covid-19 Active Cases India Jan 21 Highlights, Omicron Variant Cases in India, Coronavirus 3rd Wave, Covid-19 Vaccine Dose ...

India, Feb. 1 -- A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate,cb1, capable of generating broad immunity ...